Microsulis MEA System Labeling Changes Gain OB-GYN Panel’s Support
This article was originally published in The Gray Sheet
Executive Summary
Users of the Microsulis MEA microwave endometrial ablation system should be trained by experienced physicians, FDA's Obstetrics & Gynecology Devices Panel recommended June 10
You may also be interested in...
Microsulis launches MEA system
U.S. commercial use of minimally invasive microwave endometrial ablation device for uterine lining ablation commences Oct. 6 following PMA approval Sept. 23. Microsulis is training physicians on the device, as was recommended in a June FDA approval condition (1"The Gray Sheet" June 16, 2003, p. 28)...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.